Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial-Reference-Cited by-同舟云学术

Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial

Published:2013-02-22 Issue:5 Volume:13 Page:1203-1216
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Eisen H. J.¹,Kobashigawa J.²,Starling R. C.³,Pauly D. F.⁴,Kfoury A.⁵,Ross H.⁶,Wang S.-S.⁷,Cantin B.⁸,Van Bakel A.⁹,Ewald G.¹⁰,Hirt S.¹¹,Lehmkuhl H.¹²,Keogh A.¹³,Rinaldi M.¹⁴,Potena L.¹⁵,Zuckermann A.¹⁶,Dong G.¹⁷,Cornu-Artis C.¹⁸,Lopez P.¹⁸

Affiliation:

1. Division of Cardiology, Drexel University College of Medicine; Hahnemann University Hospital; Philadelphia; PA

2. Cedars-Sinai Heart Institute; Los Angeles; CA

3. Kaufman Center for Heart Failure; Heart and Vascular Institute, Cleveland Clinic Foundation; Cleveland; OH

4. Division of Cardiovascular Medicine; University of Florida College of Medicine; Gainesville; FL

5. Intermountain Medical Center; Salt Lake City; UT

6. Department of Cardiology/Heart Transplant; University Health Network, Toronto General Hospital; Toronto; Ontario; Canada

7. Division of Cardiovascular Surgery; National Taiwan University; Taipei; Taiwan

8. Quebec Heart Institute; Quebec; Quebec; Canada

9. Medical University of South Carolina; Charleston; SC

10. Washington University School of Medicine; St. Louis; MO

11. University Hospital Regensburg; Regensburg; Germany

12. German Heart Center Berlin; Berlin; Germany

13. Heart and Lung Transplant Unit, St. Vincents Hospital; Darlinghurst; Sydney; Australia

14. Az.Ospedaliero-Universitaria; S.Giovanni Battista di Torino; Torino; Italy

15. School of Medicine; University of Bologna; Bologna; Italy

16. Department of Cardiothoracic Surgery; University of Vienna; Vienna; Austria

17. Novartis Pharmaceuticals; East Hanover; NJ

18. Novartis Pharma AG; Basel; Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference27 articles.

1. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009;Taylor;J Heart Lung Transplant,2009

2. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients;Eisen;N Engl J Med,2003

3. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial;Keogh;Circulation,2004

4. Long-term cardiovascular risk in transplantation: Insights from the use of everolimus in heart transplantation;Eisen;Nephrol Dial Transplant,2006

5. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators;Kobashigawa;Transplantation,1998

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolutions in Combined Heart-Kidney Transplant;Current Heart Failure Reports;2024-01-17

2. Special Patient Populations;Clinical Lipidology;2024

3. Prevalence and clinical characteristics of oral lesions in heart transplant patients induced by sirolimus and everolimus: a systematic review and meta-analysis on a global scale;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-01

4. Quantitative flow ratio computed from invasive coronary angiography as a predictor for cardiac allograft vasculopathy after cardiac transplant;The International Journal of Cardiovascular Imaging;2023-12-20

5. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management. A report from the CMV International Symposium 2023;Transplant Infectious Disease;2023-11-09